GET THE APP

Cyclodextrin: An overview | Abstract
international journal of bioassays.
All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Cyclodextrin: An overview

Author(s): Nisar Ahmad Khan *, Mohi Durakshan

Abstract

Cyclodextrins are versatile pharmaceutical excipients used to enhance the solubility, stability, safety and bioavailability of drugs. Besides, being used to reduce gastrointestinal drug irritation, convert liquid drugs into microcrystalline or amorphous powder, and prevent drug–drug and drug–excipient interactions, they have shown to display adjuvant activity in vaccine therapy, prophylactic and therapeutic use in the treatment of several host-pathogen infections. Cyclodextrins (CDs) are chemically cyclic oligosaccharides which have been recognized as useful pharmaceutical excipients. The molecular structure of these glucose derivatives generates a hydrophilic exterior surface and a non-polar cavity interior. Such CDs can interact with appropriate size drug molecules which lead to the formation of inclusion complexes A number of CDs based products are available in the market based on their ability to camouflage undesirable physicochemical properties of drugs. Current review enlightens the various aspects of CD’S with regard to their chemical characteristics, properties, approaches used for complexation, characterization techniques, uses along with and future potential.

https://1xbetx.fun https://bahiscom.fun https://casibomagiris.com https://cratosslot.fun https://grandpashabet.fun https://holiganbet.fun https://holiganbet-giris.info https://jojobet.fun https://jojobetgiris.xyz https://kralbet.fun https://meritking.fun https://vdcasino.fun https://onwin.direct https://cypocafe.com https://sahabetgiris.fun

Share this article


International Journal of Bioassays is a member of the Publishers International Linking Association, Inc. (PILA), CROSSREF and CROSSMARK (USA). Digital Object Identifier (DOI) will be assigned to all its published content.

International Journal of Bioassays [ISSN: International Journal of Bioassays] is licensed under
Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
© Copyright 2012-2024. All rights reserved.